These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
185 related articles for article (PubMed ID: 37669981)
1. Glycerol biosynthetic pathway plays an essential role in proliferation and antioxidative defense in the human enteric protozoan parasite Entamoeba histolytica. Jeelani G; Balogun EO; Husain A; Nozaki T Sci Rep; 2023 Sep; 13(1):14596. PubMed ID: 37669981 [TBL] [Abstract][Full Text] [Related]
2. Discovery of Antiamebic Compounds That Inhibit Cysteine Synthase From the Enteric Parasitic Protist Mori M; Tsuge S; Fukasawa W; Jeelani G; Nakada-Tsukui K; Nonaka K; Matsumoto A; Ōmura S; Nozaki T; Shiomi K Front Cell Infect Microbiol; 2018; 8():409. PubMed ID: 30568921 [TBL] [Abstract][Full Text] [Related]
3. Dramatic increase in glycerol biosynthesis upon oxidative stress in the anaerobic protozoan parasite Entamoeba histolytica. Husain A; Sato D; Jeelani G; Soga T; Nozaki T PLoS Negl Trop Dis; 2012; 6(9):e1831. PubMed ID: 23029590 [TBL] [Abstract][Full Text] [Related]
4. Genetic, metabolomic and transcriptomic analyses of the de novo L-cysteine biosynthetic pathway in the enteric protozoan parasite Entamoeba histolytica. Jeelani G; Sato D; Soga T; Nozaki T Sci Rep; 2017 Nov; 7(1):15649. PubMed ID: 29142277 [TBL] [Abstract][Full Text] [Related]
5. Characterization and validation of Entamoeba histolytica pantothenate kinase as a novel anti-amebic drug target. Nurkanto A; Jeelani G; Yamamoto T; Naito Y; Hishiki T; Mori M; Suematsu M; Shiomi K; Hashimoto T; Nozaki T Int J Parasitol Drugs Drug Resist; 2018 Apr; 8(1):125-136. PubMed ID: 29518650 [TBL] [Abstract][Full Text] [Related]
6. Eukaryotic translation initiation factor 5A and its posttranslational modifications play an important role in proliferation and potentially in differentiation of the human enteric protozoan parasite Entamoeba histolytica. Jeelani G; Nozaki T PLoS Pathog; 2021 Feb; 17(2):e1008909. PubMed ID: 33592076 [TBL] [Abstract][Full Text] [Related]
8. Mass spectrometric analysis of L-cysteine metabolism: physiological role and fate of L-cysteine in the enteric protozoan parasite Entamoeba histolytica. Jeelani G; Sato D; Soga T; Watanabe H; Nozaki T mBio; 2014 Nov; 5(6):e01995. PubMed ID: 25370494 [TBL] [Abstract][Full Text] [Related]
10. Identification and characterization of archaeal-type FAD synthase as a novel tractable drug target from the parasitic protozoa Wulansari D; Jeelani G; Yazaki E; Nozaki T mSphere; 2024 Sep; 9(9):e0034724. PubMed ID: 39189775 [TBL] [Abstract][Full Text] [Related]
11. Identification of natural inhibitors of Entamoeba histolytica cysteine synthase from microbial secondary metabolites. Mori M; Jeelani G; Masuda Y; Sakai K; Tsukui K; Waluyo D; Tarwadi ; Watanabe Y; Nonaka K; Matsumoto A; Ōmura S; Nozaki T; Shiomi K Front Microbiol; 2015; 6():962. PubMed ID: 26441896 [TBL] [Abstract][Full Text] [Related]
12. Quantitative Proteomics Reveals Metabolic Reprogramming in Host Cells Induced by Trophozoites and Intermediate Subunit of Gal/GalNAc Lectins from Entamoeba histolytica. Zhao Y; Li X; Zhou R; Zhang L; Chen L; Tachibana H; Feng M; Cheng X mSystems; 2022 Apr; 7(2):e0135321. PubMed ID: 35343800 [TBL] [Abstract][Full Text] [Related]
13. Bioactivity of Farnesyltransferase Inhibitors Against Probst A; Nguyen TN; El-Sakkary N; Skinner D; Suzuki BM; Buckner FS; Gelb MH; Caffrey CR; Debnath A Front Cell Infect Microbiol; 2019; 9():180. PubMed ID: 31192168 [TBL] [Abstract][Full Text] [Related]
15. Target identification and intervention strategies against amebiasis. Nagaraja S; Ankri S Drug Resist Updat; 2019 May; 44():1-14. PubMed ID: 31112766 [TBL] [Abstract][Full Text] [Related]
16. Queuine Is a Nutritional Regulator of Entamoeba histolytica Response to Oxidative Stress and a Virulence Attenuator. Nagaraja S; Cai MW; Sun J; Varet H; Sarid L; Trebicz-Geffen M; Shaulov Y; Mazumdar M; Legendre R; Coppée JY; Begley TJ; Dedon PC; Gourinath S; Guillen N; Saito-Nakano Y; Shimokawa C; Hisaeda H; Ankri S mBio; 2021 Mar; 12(2):. PubMed ID: 33688012 [TBL] [Abstract][Full Text] [Related]
17. Entamoeba thiol-based redox metabolism: A potential target for drug development. Jeelani G; Nozaki T Mol Biochem Parasitol; 2016; 206(1-2):39-45. PubMed ID: 26775086 [TBL] [Abstract][Full Text] [Related]
18. Revisiting Drug Development Against the Neglected Tropical Disease, Amebiasis. Shrivastav MT; Malik Z; Somlata Front Cell Infect Microbiol; 2020; 10():628257. PubMed ID: 33718258 [TBL] [Abstract][Full Text] [Related]
19. Global analysis of gene expression in response to L-Cysteine deprivation in the anaerobic protozoan parasite Entamoeba histolytica. Husain A; Jeelani G; Sato D; Nozaki T BMC Genomics; 2011 May; 12():275. PubMed ID: 21627801 [TBL] [Abstract][Full Text] [Related]
20. Proteomic Identification of Oxidized Proteins in Entamoeba histolytica by Resin-Assisted Capture: Insights into the Role of Arginase in Resistance to Oxidative Stress. Shahi P; Trebicz-Geffen M; Nagaraja S; Alterzon-Baumel S; Hertz R; Methling K; Lalk M; Ankri S PLoS Negl Trop Dis; 2016 Jan; 10(1):e0004340. PubMed ID: 26735309 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]